Harvard Clinical Endocrinology 2025

Clinical Strategies and Comprehensive Updates for State-of-the-Art Endocrine Care

Year 2025

March 26 – 30, 2025

Syllabus:  Harvard CME _ Clinical Endocrinology

Clinical Endocrinology 2025,

Overview

For 50 years, the endocrinology faculty from Harvard Medical School and Massachusetts General Hospital have offered the CME course Clinical Endocrinology—the acclaimed annual update of current endocrine diagnostic and management strategies. If you provide care to patients with endocrine disorders, this course will be invaluable to your medical decision-making and patient care.

Education to Optimize Care of Patients with Endocrine Disorders

You can rely on this program to enhance your endocrine knowledge and optimize your care of endocrine disorders with evidence-based strategies. This course provides:

• Improved screening for common conditions
• The newest clinical guidelines, including the new guidelines for primary hyperparathyroidism and hypoparathyroidism
• Expanded options for diagnosis
• State-of-the-art treatment strategies
• Guidance for challenging cases
• Updates for management of common and rare endocrine disorders
• New concepts in endocrinology and diabetes
• Pediatric endocrinology updates
• Skills advancement workshops, including thyroid ultrasound, insulin pump management, and continuous glucose monitoring (CGM)
• Dedicated time to pose your specific questions to experts

A Practical, Comprehensive Update for Busy Clinicians

This program delivers comprehensive updates to improve screening, evaluation, diagnosis, and treatment of:

• Pituitary lesions
• Pituitary hormone excess and hypopituitarism
• Adrenal conditions and incidentalomas
• Male and female reproductive conditions
• Calcium/bone disorders, including osteoporosis
• Thyroid nodules, hyper- and hypothyroidism
• Diabetes: type 1, type 2, and in pregnancy
• Obesity
• Lipid disorders

Our faculty, world renowned for their clinical, research, and teaching achievements, cover important updates and recent advances for a broad array of endocrine conditions: